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Edited by Robert BaroukiAbstract Cytochrome bd is a prokaryotic terminal oxidase
catalyzing O2 reduction to H2O. The oxygen-reducing site has
been proposed to contain two hemes, d and b595, the latter
presumably replacing functionally CuB of heme-copper oxidases.
We show that NO, in competition with O2, rapidly and potently
(Ki ¼ 100%34 nM at 70 lM O2) inhibits cytochrome bd
isolated from Escherichia coli and Azotobacter vinelandii in
turnover, inhibition being quickly and fully reverted upon NO
depletion. Under anaerobic reducing conditions, neither of the
two enzymes reveals NO reductase activity, which is proposed in
heme-copper oxidases to be associated with CuB.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Cytochrome bd is a terminal oxidase of the respiratory
chain, which is expressed by numerous bacteria preferentially
under low O2 tension or other ‘‘stress’’ conditions [1]. The
enzyme catalyses the reduction of O2 to H2O by ubi- or
menaquinol [2–5]. The reaction is electrogenic [6–8], but is not
coupled to transmembrane proton pumping [9].
Although the X-ray structure of cytochrome bd is not
available yet, this oxidase does not reveal apparent sequence
homology to oxidases of the heme-copper superfamily [10–12].
Cytochrome bd does not contain copper [13] and it is com-
posed of two diﬀerent membrane-integrated subunits, carrying
three redox cofactors: two protoheme IX groups (hemes b558
and b595) and a chlorin (heme d) [14]. The low spin heme b558 is
presumed to be involved directly in quinol oxidation [2]. The
high spin heme d is the place where O2 chemistry occurs [2],
whereas the high spin heme b595 has been proposed to play a
role analogous to that of CuB in heme-copper oxidases,
forming together with heme d a bimetallic O2-reducing site
[15–21].* Corresponding author. Fax: +39-06-4440062.
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Abbreviations: TMPD, N,N,N 0,N 0-tetramethyl-p-phenylenediamine;
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0014-5793/$22.00  2004 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2004.09.013Currently there is growing interest in interactions of terminal
oxidases with nitric oxide (NO) [22–24]. Particular emphasis is
on the mechanism by which NO rapidly and potently inhibits
these enzymes in competition with O2, as well as on the
chemistry occurring at the heme-Cu binuclear site following
NO binding. Following the hypothesis that heme-copper
oxidases are phylogenetically related to bacterial NO-reduc-
tase [25,26], it has been reported that some bacterial heme-
copper oxidases under anaerobic reducing conditions are able
to reduce NO to N2O [27–29]; such an activity has never been
tested in bd-type oxidases. Recently, cytochrome bd has been
shown to enable strictly anaerobic, pathogenic bacteria to
survive even in the presence of nanomolar O2 concentrations
[30]. In bacterial infections, NO is produced by the host as part
of the immune response, so it seems important to investigate
how NO interacts with bd-type oxidases.
In this work, we characterized the interaction of NO with
cytochrome bd-type oxidases, speciﬁcally those isolated from
Escherichia coli and Azotobacter vinelandii. In particular, we
investigated the inhibition pattern of these enzymes by NO, as
well as their ability to consume NO under anaerobic reducing
conditions.2. Materials and methods
Cytochrome bd from E. coli strain GO105/pTK1 was isolated as
described [31], omitting the ﬁnal hydroxyapatite chromatographic step.
Cytochrome bd from A. vinelandii strain MK8 overproducing cyto-
chrome bd was isolated essentially as previously reported [32].
Static absorption spectra were recorded with a double beam UV/Vis
spectrophotometer (Jasco V-550) with a light path of 1 cm.
Cytochrome bd concentration was determined from the reduced
minus ‘air-oxidized’ diﬀerence absorption spectra using De628–607 of
10.8 mM1 cm1 for the E. coli enzyme [18], and De628–605 of 12
mM1 cm1 for the A. vinelandii enzyme [32]. The concentration of
human hemoglobin (Hb), puriﬁed according to [33], is expressed on the
heme basis, using e555 of 12.5 mM1 cm1 for the deoxygenated state.
Stock solutions of NO (Air Liquide, Paris, France) were prepared by
equilibrating degassed water at room temperature with pure NO at 1
atm. NO concentration in stock solutions was measured by spectro-
photometric titration of bovine cytochrome c oxidase.
Simultaneous amperometric NO and O2 measurements were per-
formed using Clark-type selective electrodes (ISO2 and ISO-NO
MarkII, World Precision Instruments, Sarasota, FL, USA) interfaced
with a computer. The instrument is equipped with 2 mm probes in-
serted into a 1 mL gas-tight chamber. The assays were performed in 50
mM potassium phosphate buﬀer (pH 7.0) containing 40 lM EDTA,blished by Elsevier B.V. All rights reserved.
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dodecyl-b-D-maltoside (the A. vinelandii enzyme).
The apparent inhibition constant ðKiÞ for NO inhibition was esti-
mated by processing the amperometric traces using the software
MATLAB (The Mathworks, South Natick, MA). The extent of the
enzyme inhibition was assessed by ﬁrst derivative analysis of O2 traces
and plotted as a function of the NO concentration measured in
parallel.3. Results
By absorption spectroscopy, we show that cytochrome bd
both from E. coli and A. vinelandii in the reduced state binds
NO at the level of heme d yielding a Fe2þ–NO nitrosyl-adduct,
in agreement with previous reports [18,32,34]. Addition of
micromolar concentrations of NO to the reduced enzyme in-
deed shifts the absorption peak of ferrous heme d from 629 to
641 nm, giving rise to a symmetric ﬁrst derivative-shaped dif-
ference spectrum (not shown). In the present study, ascorbate
and N,N,N 0,N 0-tetramethyl-p-phenylenediamine (TMPD) were
used as reductants to avoid the use of dithionite which
promptly reacts with NO [35].
Fig. 1 shows that NO is a potent inhibitor of the O2-re-
ductase activity of cytochrome bd from E. coli with a fast
complete inhibition at [NO] P 0.5 lM. Analysis of the NO
and O2 experimental traces recorded in parallel yields an ap-
parent inhibition constant ðKiÞ for NO of 100 34 nM
ðn ¼ 10Þ at [O2] 70 lM (Fig. 1, inset). This value is not sig-
niﬁcantly diﬀerent for the A. vinelandii enzyme and is in
agreement with the observation that under similar experi-
mental conditions direct addition of 100 nM NO to the
cytochrome bd in turnover results in 50–60% inhibition of the
O2-reductase activity (not shown). At higher O2 concentration
(1 mM O2), a signiﬁcantly greater apparent Ki value (230
nM NO) was measured, proving competition between NO and
O2 (not shown).
NO in aerobic solution is spontaneously degraded by re-
acting with O2 and, when NO concentration decays below 200
nM, cytochrome bd inhibition reverts and the enzyme gradu-
ally recovers the initial (prior to the NO addition) activityFig. 1. Inhibition of cytochrome bd oxidase activity by NO. O2 and
NO traces recorded in parallel. O2-reductase activity of cytochrome bd
(17 nM) sustained by 4 mM DTT and 0.25 mM Q1 is rapidly inhibited
by addition of 1 lM NO, to be fully recovered at low NO concen-
trations (dotted box). Inset: extent of cytochrome bd inhibition at
[NO] 6 500 nM. Data do not intercept the origin as invariably ob-
served and tentatively explained by limitations in the NO electrode
response at very low NO concentrations.(Fig. 1). Kinetics of activity recovery was measured by using
oxy-Hb as NO scavenger. As shown in Fig. 2, upon NO
depletion after Hb addition, a rapid and full recovery of the
O2-reductase activity of cytochrome bd is observed. Similar
patterns were observed using the enzyme isolated from
A. vinelandii (not shown).
The ability of cytochrome bd oxidases from both E. coli and
A. vinelandii to degrade NO under anaerobic reducing condi-
tions was tested by amperometry in the 3–30 lM NO con-
centration range according to [36], by using either
dithiothreitol (DTT)/Q1 or ascorbate/TMPD as reductants. As
shown in Fig. 3, such an activity is not detected with the E. coli
enzyme, and similar results are obtained using the A. vinelandii
oxidase (not shown). In the presence of excess reductants, NO
indeed slowly decomposes at a rate that is essentially un-
changed upon addition of cytochrome bd, either pre-reduced
or as isolated.4. Discussion
Cytochrome bd has been shown to enable strictly anaerobic,
pathogenic bacteria to survive even in the presence of
nanomolar O2 concentrations [30]. As NO is produced by the
host as part of the immune response to bacterial infections, we
investigated how NO interacts with two diﬀerent bd-type ox-
idases (from E. coli and A. vinelandii) under both aerobic and
anaerobic conditions.
In agreement with previous reports [18,32,34], by ab-
sorption spectroscopy we showed that the ferrous heme d of
cytochrome bd oxidases binds NO, like CO and O2, giving
rise to a red shift of its absorption band at 630 nm.
Turnover of both the bd-type oxidases tested in this study
was promptly inhibited by NO (Figs. 1 and 2), a ﬁnding
consistent with the observation that respiration of E. coli
cells expressing cytochrome bd is sensitive to NO [37]. The
estimated apparent Ki value (100 34 nM at 70 lM O2) is
comparable to that of mammalian cytochrome c oxidase
(60 nM at 30 lM O2, cf. [38]), and is dependent on O2
concentration, as previously demonstrated for the mito-
chondrial enzyme [38]. The latter observation leads to theFig. 2. Recovery of cytochrome bd oxidase activity upon NO scav-
enging. Conditions as in Fig. 1, except that, about 3 min after addition
of 3 lMNO, 15 lMHb-O2 was added to promptly scavenge bulk NO,
resulting in a fast and complete recovery of the enzyme activity.
Fig. 3. NO reductase activity test. Three aliquots of 1.5 lM NO were
successively added to degassed buﬀer containing 4 mM DTT, 0.25 mM
Q1, as well as 5 mM ascorbate and 5 units/mL ascorbate oxidase to
scavenge residual O2. Addition of 70 nM E. coli cytochrome bd,
though associated with a small decrease in NO concentration (partly
due to NO binding to the enzyme), did not signiﬁcantly change the rate
of NO consumption.
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occurs in competition with O2 and that in vivo at very low
O2 concentration NO inhibition should be even more ef-
fective. Assuming that NO and O2 combine with ferrous
heme d with similar rates, as originally proposed for mi-
tochondrial cytochrome c oxidase [39], the fast onset of
inhibition by NO even in the presence of a large excess O2
suggests the existence of catalytic intermediates displaying
preferential reactivity for NO over O2 (see [23] for a review
on this issue). Such a hypothesis demands further
investigation.
The NO inhibition of the isolated cytochrome bd oxidases is
fully reversible (Figs. 1 and 2), as previously shown for cyto-
chrome c oxidase [38–40]. Following NO depletion upon ad-
dition of excess oxy-Hb, the recovery of activity appears to be
faster in the bd oxidases than in mitochondrial cytochrome c
oxidase assayed under similar conditions, i.e. in the presence of
excess reductants [41]. Under such conditions, the recovery of
activity of the mitochondrial enzyme is rate-limited by NO
dissociation from the enzyme into the bulk phase [41].
Therefore, if a similar Fe2þ–NO adduct forms in the bd ox-
idases, the faster recovery of activity should correlate with a
higher koff of NO dissociation from reduced cytochrome bd.
Diﬀerently from some bacterial heme-copper oxidases [27–
29], the oxidases of the bd-type tested in this study do not
reveal NO reductase activity (<0.1 mol NO/mol bdmin to be
compared for instance with 100 mol NO/mol enzymemin,
as measured for the cytochrome cbb3 oxidase from Pseudo-
monas stutzeri [28]). The inability of cytochrome bd to catalyze
the reduction of NO suggests that CuB plays a key role in this
reaction, as originally proposed [27]. Thus, the presence of a
non-heme metal ion in the active site (either FeB in bacterial
NO reductase [42,43], or CuB in heme-copper oxidases) seems
to be a prerequisite for the NO reductase activity in terminal
oxidases. Moreover, the lack of such an activity in the mito-
chondrial beef heart cytochrome c oxidase [36] and in the
‘‘nitric oxide reductase homolog’’ from Roseobacter denitriﬁ-cans [44], both containing a copper ion in the binuclear site,
suggests that the reduction of NO by terminal oxidases re-
quires speciﬁc structural features of CuB surroundings [27],
probably modulating the aﬃnity of CuþB for NO. In this con-
text it is of interest that, upon CO photolysis, CuþB acts as a
better trap for the photodissociated ligand in those oxidases
endowed with NO-reductase activity [45,46]. Accordingly, no
transient binding of photodissociated CO to reduced heme b595
has been measured in bd-oxidases [21]. On this basis, the low
aﬃnity for CO and NO reported for ferrous heme b595
[15,17,18,20,32], possibly replacing functionally CuB in bd
oxidases, may provide a rationale for the lack of NO-reductase
activity in this enzyme. An important physiological corollary is
that cytochrome bd does not contribute signiﬁcantly to bac-
terial NO detoxiﬁcation mechanisms, which are dominated
aerobically by the ﬂavohemoglobin Hmp [37].
In conclusion, we provide evidence that the bd-type bacterial
terminal oxidases tested in this study are: (i) quickly, potently
and reversibly inhibited by NO (as mitochondrial cytochrome
c oxidase) and (ii) unable to degrade NO under reductive
anaerobic conditions.
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